- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected. By carrying out comprehensive studies on mice with human tumors, scientists at the University of California, Los Angeles, have obtained results that move the research one step closer to this goal.
In a paper published in the journal Small, Fuyuhiko Tamanoi and colleagues demonstrated that mesoporous silica nanoparticles (MSNs), can store and deliver chemotherapeutic drugs in vivo and effectively suppress tumors in mice. The investigators also showed that MSNs accumulate almost exclusively in tumors after administration and that the nanoparticles are excreted from the body after they have delivered their chemotherapeutic drugs.
In the study, Dr. Tamanoi and his colleagues found that MSNs circulate in the bloodstream for extended periods of time and accumulate predominantly in tumors. The tumor accumulation could be further improved by attaching a targeting moiety to MSNs, the researchers said.
Treating mice with camptothecin-loaded MSNs led to shrinkage and regression of xenograft tumors. By the end of the treatment, the mice were essentially free of tumors, and acute and long-term toxicity of MSNs to the mice was negligible. Mice with breast cancer were used in this study, but the researchers have recently obtained similar results using mice with human pancreatic cancer.
Two properties of these nanoparticles proved important in creating this promising anticancer therapy, according to the investigators. First, these nanoparticles appear to evade the surveillance mechanism that normally removes materials foreign to the body, enabling the nanoparticles to accumulate in tumors. Second, most of the nanoparticles that were injected into the mice were excreted out through urine and feces within four days. The latter results, say the investigators, was somewhat of a surprise and might explain the low toxicity observed in the biocompatibility experiments they conducted.
This work is detailed in a paper titled, "Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals." An abstract of this paper is available at the journal's Web site.
About NCI Alliance for Nanotechnology in Cancer
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Copyright © NCI Alliance for Nanotechnology in CancerIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
'Material universe' yields surprising new particle November 28th, 2015
New 'self-healing' gel makes electronics more flexible November 25th, 2015
Pioneering research boosts graphene revolution November 17th, 2015
Iran Signs MoU to Export Nanodevices to China November 9th, 2015
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Using light-force to study single molecules November 23rd, 2015
Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015